Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 185

Intel gets on MIC in series A round

Intel Capital and Texas Medical Center Venture Fund were among the participants in an $11.9m round for patient monitoring system developer Medical Informatics.

Apr 8, 2019

Boehringer Ingelheim regenerates Agomab

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer that was co-led by V-Bio Ventures and Advent France Biotechnology.

Apr 8, 2019

Corporate venturing deal net: 1-5 April 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Apr 5, 2019

Deal net: 1 – 5 April 2019

The Global University Venturing Deal Net rounds up the week’s smaller deals and tracks the startups emerging from universities and raising funding.

Apr 5, 2019

Nautilus Labs ships in $11m

The nautical shipping management platform raised $11m in a Microsoft-led series A round, adding to $3.5m in earlier funding.

Apr 5, 2019

Hungry devours $8m

Catering services marketplace Hungry has now raised $12.5m in total, having added university venture unit James Madison Innovations to its investment consortium.

Apr 5, 2019

Polystream pulls in $12m from series A

The 3D game streaming platform has collected $12m in an Intel Capital-led round that also featured Wargaming Group, with the funds to go to hiring.

Apr 4, 2019

Intel helps break off $13m for Untether AI

AI chip developer Untether AI has secured funding in an Intel Capital-led series A round, the proceeds of which will fund development of the startup's technology.

Apr 4, 2019

Mints chips in to $6m Movellus round

University of Michigan’s Mints vehicle joined existing investor Intel Capital for SOC producer Movellus’ series A round, which increased the company's overall funding to $10m.

Apr 3, 2019

NextGen Jane nets $9m in series A funding

NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.

Apr 3, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here